Diabetes, Vol 36, Issue 8 963-970, Copyright © 1987 by American Diabetes Association

ARTICLES

Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans

PG Comens, BA Wolf, ER Unanue, PE Lacy and ML McDaniel

The effects of interleukin 1 (IL-1) on glucose-induced insulin secretion from isolated rat islets of Langerhans have been examined. IL-1 both inhibits and stimulates glucose-induced insulin secretion depending on the experimental design. Inhibition of glucose-induced insulin secretion was observed after a 15-h treatment of islets with either purified IL-1, murine recombinant IL-1 (rIL-1), or human rIL-1, rIL-1 inhibition of glucose-induced insulin secretion was dose dependent with half-maximal inhibition observed at 25 pM human rIL-1. Basal insulin secretion was not affected by rIL-1 treatment. Mannose- and leucine-induced insulin secretion was also inhibited by a 15-h treatment with human rIL-1. Islets treated 15 h with inhibitory concentrations of murine IL-1 were morphologically intact, well granulated, and retained normal concentrations of insulin compared with control islets. Furthermore, human rIL-1 treatment did not affect the islet plasma membrane permeability as assessed by the measurement of the islet intracellular volume. Finally, the viability of islets treated 15 h with murine rIL-1 was demonstrated by the observation that the inhibitory effects of murine rIL-1 on glucose-induced insulin secretion were reversible. In addition to the inhibitory effects of IL-1 on glucose-induced insulin secretion, purified IL-1 and human rIL-1 had stimulatory effects on glucose-induced insulin secretion under the following conditions: a 90-min incubation with purified IL-1 (10% vol/vol) or in the presence of human rIL-1 (1400 pM) or a 15-h incubation with relatively low concentrations of human rIL-1 (0.5 or 5 pM).(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. Emanuelli, M. Glondu, C. Filloux, P. Peraldi, and E. Van Obberghen The Potential Role of SOCS-3 in the Interleukin-1{beta}-Induced Desensitization of Insulin Signaling in Pancreatic Beta-Cells Diabetes, December 1, 2004; 53(suppl_3): S97 - S103. [Abstract] [Full Text] [PDF]

				X. Cao, Z. Gao, C. E. Robert, S. Greene, G. Xu, W. Xu, E. Bell, D. Campbell, Y. Zhu, R. Young, et al. Pancreatic-Derived Factor (FAM3B), a Novel Islet Cytokine, Induces Apoptosis of Insulin-Secreting {beta}-Cells Diabetes, September 1, 2003; 52(9): 2296 - 2303. [Abstract] [Full Text] [PDF]

				A. L. Scarim, S. Y. Nishimoto, S. M. Weber, and J. A. Corbett Role for c-Jun N-Terminal Kinase in {beta}-Cell Recovery from Nitric Oxide-Mediated Damage Endocrinology, August 1, 2003; 144(8): 3415 - 3422. [Abstract] [Full Text] [PDF]

				P. O. T. Tran, C. E. Gleason, and R. P. Robertson Inhibition of Interleukin-1{beta}-Induced COX-2 and EP3 Gene Expression by Sodium Salicylate Enhances Pancreatic Islet {beta}-Cell Function Diabetes, June 1, 2002; 51(6): 1772 - 1778. [Abstract] [Full Text] [PDF]

				P. O. T. Tran, C. E. Gleason, V. Poitout, and R. P. Robertson Prostaglandin E2 Mediates Inhibition of Insulin Secretion by Interleukin-1beta J. Biol. Chem., October 29, 1999; 274(44): 31245 - 31248. [Abstract] [Full Text] [PDF]

				A. L. Scarim, M. R. Heitmeier, and J. A. Corbett Heat Shock Inhibits Cytokine-Induced Nitric Oxide Synthase Expression by Rat and Human Islets Endocrinology, December 1, 1998; 139(12): 5050 - 5057. [Abstract] [Full Text] [PDF]

				D. J. Gross, L. Weiss, I. Reibstein, J. van den Brand, H. Okamoto, A. Clark, and S. Slavin Amelioration of Diabetes in Nonobese Diabetic Mice with Advanced Disease by Linomide-Induced Immunoregulation Combined with Reg Protein Treatment Endocrinology, May 1, 1998; 139(5): 2369 - 2374. [Abstract] [Full Text] [PDF]

				A. L. Scarim, M. R. Heitmeier, and J. A. Corbett Irreversible Inhibition of Metabolic Function and Islet Destruction after a 36-Hour Exposure to Interleukin-1{beta} Endocrinology, December 1, 1997; 138(12): 5301 - 5307. [Abstract] [Full Text] [PDF]

				Z. Ma, M. Landt, A. Bohrer, S. Ramanadham, D. M. Kipnis, and J. Turk Interleukin-1 Reduces the Glycolytic Utilization of Glucose by Pancreatic Islets and Reduces Glucokinase mRNA Content and Protein Synthesis by a Nitric Oxide-dependent Mechanism J. Biol. Chem., July 11, 1997; 272(28): 17827 - 17835. [Abstract] [Full Text] [PDF]

				M. O. Kurrer, S. V. Pakala, H. L. Hanson, and J. D. Katz beta cell apoptosis in T cell-mediated autoimmune diabetes PNAS, January 7, 1997; 94(1): 213 - 218. [Abstract] [Full Text] [PDF]